Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,588 GBX | +0.32% | -3.47% | +9.40% |
Apr. 17 | GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix | MT |
Apr. 17 | GSK: positive clinical results for gonorrhea | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.40% | 80.65B | |
+27.97% | 672B | |
+23.65% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.30% | 211B | |
-0.47% | 203B | |
-9.94% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Transcript : GlaxoSmithKline plc, Q1 2022 Earnings Call, Apr 27, 2022